Institutional members access full text with Ovid®

Share this article on:

Hematologic Manifestations of Brucellosis in Children

Justman, Naphtali, MMedSc*,†; Fruchtman, Yariv, MD*,†; Greenberg, David, MD*,†; Ben-Shimol, Shalom, MD*,†

The Pediatric Infectious Disease Journal: June 2018 - Volume 37 - Issue 6 - p 586–591
doi: 10.1097/INF.0000000000001900
Pathogenesis and Host Response

Background: Brucellosis is a common zoonosis in the Bedouin population of southern Israel. Limited data exist for the rate and risk factors of hematologic complication of brucellosis in children. We assessed anemia, leukopenia, thrombocytopenia and pancytopenia in childhood brucellosis in southern Israel.

Methods: Our medical center is the sole hospital in southern Israel. All medical files of brucellosis, 2005–2014, identified through positive blood cultures or International Classification of Diseases 9th revision coding with positive serology, were reviewed retrospectively.

Results: Overall, 511 brucellosis episodes were identified; 42% (N = 214) with ≥1 cytopenia, including 13% (N = 68) anemia, 28% (N = 144) leukopenia, 14% (N = 74) thrombocytopenia and 2% (N = 9) pancytopenia. Overall, 99.8% of episodes were in Bedouin children and 70% in males. In 79% of episodes, blood culture was positive for Brucella melitensis. Acute infections comprised 84% of all episodes. In univariate analysis, older age (10.49 ± 4.81 vs. 9.25 ± 4.89 years), fever (92% vs. 78%), positive blood culture (84% vs. 75%) and IgM ≥1:640 levels (50% vs. 39%) were associated with cytopenia. In contrast, arthralgia was associated with noncytopenic episodes. In multivariate analyses, older age (odds ratio = 1.063) and fever (odds ratio = 3.127) were associated with cytopenia.

Conclusions: Brucellosis is commonly presented with cytopenia, especially in bacteremic episodes with fever. However, pancytopenia is uncommon and its finding should alert the physician to look for other possible etiologies.

From the *The Pediatric Infectious Disease Unit

The Faculty of Health Sciences, Joyce & Irving Goldman Medical School at Ben Gurion University of the Negev, Israel; Soroka University Medical Center, Beer-Sheva, Israel.

Accepted for publication December 11, 2017.

The authors have no funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).

Address for correspondence: Shalom Ben-Shimol, MD, Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel. E-mail: shalomb2@clalit.org.il.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.